Targeted Inhibition of Calcineurin in Pressure-overload Cardiac Hypertrophy
Open Access
- 1 March 2002
- journal article
- Published by Elsevier BV
- Vol. 277 (12), 10251-10255
- https://doi.org/10.1074/jbc.m110722200
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- gp130 Plays a Critical Role in Pressure Overload-induced Cardiac HypertrophyPublished by Elsevier BV ,2001
- Na+-Ca2+ Exchanger Remodeling in Pressure Overload Cardiac HypertrophyPublished by Elsevier BV ,2001
- Cardiac Overexpression of a G q Inhibitor Blocks Induction of Extracellular Signal–Regulated Kinase and c-Jun NH 2 -Terminal Kinase Activity in In Vivo Pressure OverloadCirculation, 2001
- Cytoplasmic Signaling Pathways That Regulate Cardiac HypertrophyAnnual Review of Physiology, 2001
- An abnormal Ca2+ response in mutant sarcomere protein–mediated familial hypertrophic cardiomyopathyJCI Insight, 2000
- CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivoJCI Insight, 2000
- Calcineurin Plays a Critical Role in Pressure Overload–Induced Cardiac HypertrophyCirculation, 1999
- Regulation of cardiac hypertrophy in vivo by the stress-activated protein kinases/c-Jun NH2-terminal kinasesJCI Insight, 1999
- Genomic Organization, Alternative Splicing, and Expression Patterns of theDSCR1(Down Syndrome Candidate Region 1) GeneGenomics, 1997
- Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy.Proceedings of the National Academy of Sciences, 1991